Mechanisms of allergic rhinitis

Current Allergy and Asthma Reports

Volumn 1, Issue 3, 2001, Pages 207-217

  Baraniuk, James N ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

Allergic Rhinitis; Allergy Clin Immunol; Mast Cell; Rhinitis; Vasoactive Intestinal Polypeptide

Indexed keywords

ALGORITHM; CYTOLOGY; DIFFERENTIAL DIAGNOSIS; HUMAN; MAST CELL; NOSE MUCOSA; PATHOPHYSIOLOGY; PERENNIAL RHINITIS; PHYSIOLOGY; REVIEW;

ALGORITHMS; DIAGNOSIS, DIFFERENTIAL; HUMANS; MAST CELLS; NASAL MUCOSA; RHINITIS, ALLERGIC, PERENNIAL;

EID: 0035353083     PISSN: 15297322     EISSN: 15346315     Source Type: Journal    
DOI: 10.1007/s11882-001-0007-5     Document Type: Article

References (78)

1. Baraniuk JN: Pathogenesis of allergic rhinitis. J Allergy Clin Immunol 1997, 99:S763-S772. DOI: 10.1016/S0091-6749(97)70125-8
2. Druce HM: Allergic and nonallergic rhinitis. In Allergy Principles and Practice edn 4. Edited by Middleton E Jr, Reed CE, Ellis E, et al. St. Louis: Mosby; 1993:1433–1453.
3. Togias A: Non-allergic rhinitis. In Allergic and Non-Allergic Rhinitis—Clinical Aspects. Edited by Mygind N, Naclerio RM. Philadelphia: Saunders; 1993:159–166.
4. Andersson M, Greiff L, Svensson C, et al.: Allergic and nonallergic rhinitis. In Asthma and Rhinitis. Edited by Busse WW, Holgate ST. Boston: Blackwell Scientific; 1995:145–155.
5. Kaliner MA: Allergic rhinitis. In Allergic and Non-Allergic Rhinitis—Clinical Aspects. Edited by Mygind N, Naclerio RM. Philadelphia: Saunders; 1993:152–158.
6. Mygind N, Dahl R, Pedersen S, Thestrup-Pedersen K: Essential Allergy edn 2. Oxford: Blackwell Science; 1996:206–208.
7. Raphael GD, Meredith SD, Baraniuk JN, et al.: The pathophysiology of rhinitis: II: assessment of the sources of protein in histamine-induced nasal secretions. Am Rev Respir Dis 1989, 139:791–800.
8. Baraniuk JN, Clauw JD, Gaumond E: Rhinitis symptoms in chronic fatigue syndrome. Ann Allergy Asthma Immunol 1998, 81:359–365. DOI: 10.1016/S1081-1206(10)63129-8
9. Baraniuk JN, Clauw D, Yuta A, et al.: Nasal secretion analysis in allergic rhinitis, cystic fibrosis, and nonallergic fibromyalgia/ Chronic Fatigue Syndrome subjects. Am J Rhinol 1998, 12:435–440. DOI: 10.2500/105065898780707964
10. Baraniuk JN, Ali M, Yuta A, et al.: Hypertonic saline nasal provocation stimulates nociceptive nerves, substance P release, and glandular mucus exocytosis in normal humans. Am J Respir Crit Care Med 1999, 160:655–662. This article demonstrates that normal human airway nociceptive nerve axon responses cause SP release, which presumably acts on neurokinin-1 receptors on glands to stimulate exocytosis. No vascular leak or permeability was found. This is strikingly different from the "neurogenic inflammation" found in rodent tracheal airways, which had previously led to the conclusion that vascular permeability was the primary endpoint of this reaction.
11. Bonini S, Bonini O, Lambiase A, et al.: Vernal keratoconjunctivitis: a model of 5q cytokine gene cluster disease. Int Arch Allergy Immunol 1995, 107:95–98. DOI: 10.1159/000236942
12. Mareni C, Sessarego M, Montera M, et al.: Expression and genomic configuration of GM-CSF, IL-3, M-CSR receptor (C-FMS), early growth response gene-1 (EGR-1) and M-CSF genes in primary myelodysplastic syndromes. Leuk Lymphoma 1994, 15:135–141.
13. Frazer KA, Ueda Y, Zhu Y, et al.: Computational and biological analysis of 680 kb of DNA sequence from the human 5q31 cytokine gene cluster region. Genome Res 1997, 7:495–512.
14. Smirnov DV, Smirnova MG, Korobko VG, Frolova EI: Tandem arrangement of human genes for interleukin-4 and interleukin-13: resemblance in their organization. Gene 1995, 155:277–281. DOI: 10.1016/0378-1119(94)00720-D
15. Kruskal J, Xiong M, Ferrell R, et al.: Linkage and association of adrenergic and dopamine receptor genes in the distal portion of the long arm of chromosome 5 with systemic blood pressure variation. Hum Mol Genet 1998, 7:1379–1383. DOI: 10.1093/hmg/7.9.1379
16. Coombs RRA, Gell PGH: The classification of allergic reactions underlying disease. In Clinical Aspects of Immunology. Edited by Gell PGH, Coombs RRA. Oxford: Blackwell Scientific; 1963:317–337.
17. Iliopoulos O, Proud D, Adkinson F Jr, et al.: Effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells. J Allergy Clin Immunol 1991, 87:855–866. DOI: 10.1016/0091-6749(91)90134-A
18. Cameron L, Hamid Q, Wright E, et al.: Local synthesis of epsilon germline gene transcripts, IL-4, and IL-13 in allergic nasal mucosa after ex vivo allergen exposure. J Allergy Clin Immunol 2000 106:46–52. Local nasal mucosal production of IgE is demonstrated in nasal explants, indicating that IgE plasma cells can differentiate in this tissue ex vivo. DOI: 10.1067/mai.2000.107398
19. Bradding P, Okayama Y, Howarth PH, et al.: Heterogeneity of human mast cells based on cytokines content. J Immunol 1995, 155:297–307.
20. Bradding P, Mediwake R, Feather IH, et al.: TNF-a is localized to nasal mucosal mast cells and is released in acute allergic rhinitis. Clin Exp Allergy 1995, 25:406–415. DOI: 10.1111/j.1365-2222.1995.tb01071.x
21. Pawankar RU, Okuda M, Hasegawa S, et al.: Interleukin-13 expression in the nasal mucosal of perennial allergic rhinitis. Am J Respir Crit Care Med 1995, 152:2059–2067.
22. Juluisson S, Aldenborg F, Enerback L: Protease content of mast cells of nasal mucosa: effects of natural allergen exposure and of local corticosteroid treatment. Allergy 1995, 50:15–22. DOI: 10.1111/j.1398-9995.1995.tb02478.x
23. Kawabori Y, Kanai N, Tosho T: Proliferative activity of mast cells in allergic nasal mucosa. Clin Exp Allergy 1995, 25:173–178. DOI: 10.1111/j.1365-2222.1995.tb01023.x
24. Simons FE: Histamine and H1-Antagonists in Allergic Disease. New York: Marcel Dekker; 1996.
25. Terada N, Kono A, Togawa K: Biochemical properties of eosinophils and their preferential accumulation mechanism in nasal allergy. J Allergy Clin Immunol 1994, 94:629–642. DOI: 10.1016/0091-6749(94)90140-6
26. Naclerio RM, Baroody FM, Kagey-Sobotka A, Lichtenstein LM: Basophils and eosinophils in allergic rhinitis. J Allergy Clin Immunol 1994, 94:1303–1309. DOI: 10.1016/0091-6749(94)90346-8
27. Holgate ST, Bradding BM, Sampson AP: Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy. J Allergy Clin Immunol 1996, 98:1–13. DOI: 10.1016/S0091-6749(96)70220-8
28. Sommerhof CP, Caughey GH, Finkbeiner WE, et al.: Mast cell chymase: a potent secretagogue for airway gland serous cells. J Immunol 1989, 142:2450–2456.
29. Erjefalt I, Persson CG: Allergen, bradykinin, and capsaicin increase outward but not inward macromolecular permeability of guinea-pig tracheobronchial mucus. Clin Exp Allergy 1991, 21:217–224. DOI: 10.1111/j.1365-2222.1991.tb00833.x
30. Iriyoshi N, Takeuchi K, Yuta A, et al.: Increased pathology of allergic rhinitis: expression of histamine H1 receptor mRNA in allergic rhinitis. Clin Exp Allergy 1996, 26:379–385. DOI: 10.1111/j.1365-2222.1996.tb00553.x
31. Okayama M, Baraniuk JN, Hausfeld JN, et al.: Characterization and autoradiographic localization of histamine H1 receptors in human nasal turbinates. J Allergy Clin Immunol 1992, 89:1144–1150. DOI: 10.1016/0091-6749(92)90298-G
32. Okayama M, Yamauchi K, Sekizawa K, et al.: Localization of histamine N-methyltransferase messenger RNA in human nasal mucosa. J Allergy Clin Immunol 1995, 95:96–102. DOI: 10.1016/S0091-6749(95)70157-5
33. Baraniuk JN: Neuropeptide pharmacology. In Immunopharmacology of the Respiratory Tract: Clinical Allergy and Immunology 8. Edited by Townley RG, Agarwal DK. New York: Marcel Dekker; 1996:575–603.
34. McDonald DM: Neurogenic inflammation in the respiratory tract: actions of sensory nerve mediators on blood vessels and epithelium of the airway mucosa. Am Rev Respir Dis 1987, 136:S65-S72.
35. Stjarne P, Lacroix JS, Anggard A, Lundberg JM: Compartment analysis of vascular effects of neuropeptides and capsaicin in the pig nasal mucosa. Acta Physiol Scand 1991, 141:335–342.
36. Svensson C, Andersson M, Greiff L, et al.: Exudative hyperresponsiveness of the airway microcirculation in seasonal allergic rhinitis. Clin Exp Allergy 1995, 25:942–950. DOI: 10.1111/j.1365-2222.1995.tb00396.x
37. Joos GF, Germonpre PR, Pauwels RA: Neurogenic inflammation in human airways: it is important? Thorax 1995, 50:217–219. DOI: 10.1136/thx.50.3.217
38. Fajac I, Braunstein G, Ickovic MR, et al.: Selective recruitment of eosinophils by substance P after repeated allergen exposure in allergic rhinitis. Allergy 1995, 50:970–975. DOI: 10.1111/j.1398-9995.1995.tb02509.x
39. Proud D, Reynolds CJ, Lichtenstein LM, et al.: Intranasal salmeterol inhibits allergen-induced vascular permeability but not mast cell activation or cellular infiltration. Clin Exp Allergy 1998, 28:868–875. Long-acting b2-adrenergic receptor antagonists had been touted as anti-inflammatory agents in allergic disease. This paper demonstrated that the changes were in the vascular leak component but not in other facets of seasonal allergic rhinitis. DOI: 10.1046/j.1365-2222.1998.00335.x
40. Mossiman BL, White MV, Hohman RJ, et al.: Substance P, calcitonin-gene related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients. J Allergy Clin Immunol 1993, 92:95–104. DOI: 10.1016/0091-6749(93)90043-F
41. Okamoto Y, Shirotori K, Kudo K, et al.: Cytokine expression after the topical administration of substance P to human nasal mucosa: the role of substance P in nasal allergy. J Immunol 1993, 151:4391–4398.
42. Rinder J, Lundberg JM: Effects of hCGRP8-37 and the NK1-receptor antagonist SR140.333 on capsaicin-evoked vasodilation in the pig nasal mucosa in vivo. Acta Physiol Scand 1996, 156:115–122. DOI: 10.1046/j.1365-201X.1996.431164000.x
43. Baraniuk JN, Silver PB, Kaliner MA, Barnes PJ: Effects of ipratropium bromide on bradykinin nasal provocation in humans. Clin Exp Allergy 1994, 14:724–729. DOI: 10.1111/j.1365-2222.1994.tb00982.x
44. Baraniuk JN, Kaliner MA, Barnes PJ: Localization of m3 muscarinic receptor mRNA in human nasal mucosa. Am J Rhinol 1992, 6:145–148.
45. Mullol J, Baraniuk JN, Logun C, et al.: M1 and M3 muscarinic antagonists inhibit human nasal glandular secretion in vitro. J Appl Physiol 1992, 73:2069–2073.
46. Costello RW, Jacoby DB, Gleich GJ, Fryer AD: Eosinophils and airway nerves in asthma. Histol Histopathol 2000, 15:861–868. The complex interactions of SP, eosinophil products, and dysfunction of the muscarinic M2 receptors that have been demonstrated in animal models are reviewed.
47. Evans CM, Belmonte KE, Costello RW, et al.: Substance Pinduced airway hyperreactivity is mediated by neuronal M(2) receptor dysfunction. Am J Physiol Lung Cell Mol Physiol 2000, 279:L477-L486.
48. Altman LC, Ayars GH, Baker C, Luchtel DL: Cytokines and eosinophil derived cationic proteins up-regulate intercellular adhesion molecule 1 on human nasal epithelial cells. J Allergy Clin Immunol 1993, 92:527–536. DOI: 10.1016/0091-6749(93)90077-S
49. Nonaka M, Nonaka R, Jordana M, Dolovich J: GM-CSF, IL-8, IL-1R, TNF-alpha R, and HLA-DR in nasal epithelial cells in allergic rhinitis. Am J Respir Crit Care Med 1996, 153:1675–1681.
50. Minshall EM, Cameron L, Lavigne F, et al.: Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis. Am J Respir Cell Mol Biol 1997, 17:683–690.
51. Gosset P, Malaquin F, Delnest Y, et al.: Interleukin 6 and interleukin 1b production is associated with antigen induced late nasal response. J Allergy Clin Immunol 1993, 92:878–890. DOI: 10.1016/0091-6749(93)90066-O
52. Kenney JS, Baker C, Welch MR, Altman LC: Synthesis of interleukin-1a, interleukin-6, and interleukin-8 by cultured human nasal epithelial cells. J Allergy Clin Immunol 1994, 3:1060–1067. DOI: 10.1016/S0091-6749(94)70055-9
53. Mullol J, Chowdoury BA, White MV, et al.: Endothelin in human nasal mucosa. Am J Respir Cell Mol Biol 1993, 8:393–402.
54. Furukawa K, Saleh D, Bayan F, et al.: Coexpression of endothelin 1 and endothelin converting enzyme 1 in patients with chronic rhinitis. Am J Respir Cell Mol Biol 1996, 14:248–253.
55. Martin U, Bryden K, Devoy M, Howarth P: Increased levels of exhaled nitric oxide during nasal and oral breathing in subjects with seasonal rhinitis. J Allergy Clin Immunol 1996, 7:768–772. DOI: 10.1016/S0091-6749(96)80154-0
56. Fischer A, Hoffman B: Nitric oxide synthase in neurons and nerve fibers of lower airways and in vagal sensory ganglia of man. Am J Respir Crit Care Med 1996, 154:209–216.
57. Masuda S: Quantitative histochemistry of mucus-secreting cells in human nasal mucosa. Pract Otol (Kyoto) 1990, 83:1855–1863.
58. Lou YP, Takeyama K, Grattan KM, et al.: Platelet-activating factor induces goblet cell hyperplasia and mucin gene expression in airways. Am J Respir Crit Care Med 1998, 157:1927–1934.
59. Takeyama K, Dabbagh K, Lee HM, et al.: Epidermal growth factor system regulates mucin production in airways. Proc Natl Acad Sci U S A 1999, 96:3081–3086. This paper demonstrates that cytokines such as epidermal growth factor can modulate the types of mucins and phenotype of exocrine cells in airways. DOI: 10.1073/pnas.96.6.3081
60. Sharma P, Dudus L, Nielsen PA, et al.: MUC5B and MUC7 are differentially expressed in mucous and serous cells of submucosal glands in human bronchial airways. Am J Respir Cell Mol Biol 1998, 19:30–37. This paper breached the mystery surrounding the nature of mucins and their localizations within specific airway exocrine cells.
61. Borchers MT, Carty MP, Leikauf GD: Regulation of human airway mucins by acrolein and inflammatory mediators. Am J Physiol 1999, 276:L549-L555.
62. Dabbagh K, Takeyama K, Lee HM, et al.: IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo. J Immunol 1999, 162:6233–6237.
63. Wills-Karp M: Immunologic basis of antigen-induced airway hyperresponsiveness. Ann Rev Immunol 1999, 17:255–281. This review covers many mechanisms that may lead to bronchial hyperresponsiveness. DOI: 10.1146/annurev.immunol.17.1.255
64. Voynow JA, Selby DM, Rose MC: Mucin gene expression (MUC1, MUC2, and MUC5/5AC) in nasal epithelial cells of cystic fibrosis, allergic rhinitis, and normal individuals. Lung 1998, 176:345–354. DOI: 10.1007/PL00007616
65. Voynow JA, Young LR, Wang Y, et al.: Neutrophil elastase increases MUC5AC mRNA and protein expression in respiratory epithelial cells. Am J Physiol 1999, 276:L835-L843.
66. Yuta A, Baraniuk JN: Therapeutic approaches to airway mucous hypersecretion. In Airway Mucus: Basic Mechanisms and Clinical Perspectives: Respiratory Pharmacology and Pharmacotherapy series. Edited by Rogers DF, Lethem MI. Basel: Birkhauser; 1997:365–383.
67. Ziment I: Historic overview of mucoactive drugs. In Drugs in Bronchial Mucology. Edited by Braga PC, Allegra L. New York: Raven; 1989:1–34.
68. Claman DM, Bousher HA, Lui J, et al.: Analysis of induced sputum to examine the effects of prednisone on airway inflammation in asthmatic subjects. J Allergy Clin Immunol 1994, 94:861–869. DOI: 10.1016/0091-6749(94)90154-6
69. Baroody FM, Cruz AA, Lichtenstein LM, et al.: Intranasal beclomethasone inhibits antigen induced nasal hyperresponsiveness to histamine. J Allergy Clin Immunol 1992, 90:373–376. DOI: 10.1016/S0091-6749(05)80017-X
70. White MV: Nasal cholinergic hyperresponsiveness in atopic subjects studied out of season. J Allergy Clin Immunol 1993, 92:278–287. DOI: 10.1016/0091-6749(93)90171-B
71. Figueroa JM, Mansilla E, Suburo AM: Innervation of nasal turbinate blood vessels in rhinitic and nonrhinitic children. Am J Respir Crit Care Med 1998 157:1959–1566. The innervation of human nasal mucosa is displayed in precise photomicrographs.
72. Fang SY, Shen CL: Neuropeptidergic innervation of human nasal mucosa in various pathological conditions. Proc Natl Sci Counc Repub China B 1997, 21:8–12.
73. Fang SY, Shen CL: Neuropeptide innervation and neuroendocrine cells in allergic rhinitis and chronic hypertrophic rhinitis. Clin Exp Allergy 1998, 28:228–232. DOI: 10.1046/j.1365-2222.1998.00204.x
74. Druce HM, Wright RH, Kossoff D, Kaliner MA: Cholinergic nasal hyperreactivity in atopic subjects. J Allergy Clin Immunol 1985, 76:445–452. DOI: 10.1016/0091-6749(85)90725-0
75. Kurian SS, Blank MA, Sheppard MN: Vasoactive intestinal polypeptide (VIP) in vasomotor rhinitis. Clin Biochem 1983, 11:425–426.
76. Lucchini RE, Facchini F, Turato G, et al.: Increased VIP-positive nerve fibers in the mucous glands of subjects with chronic bronchitis. Am J Respir Crit Care Med 1997, 156:1963–1968.
77. Einarsson O, Geba GP, Zhou Z, et al.: Interleukin-11 in respiratory inflammation. Ann N Y Acad Sci 1995, 762:31–40.
78. Jeney EV, Raphael GD, Meredith SD, Kaliner MA: Abnormal cholinergic parasympathetic responsiveness in the nasal mucosa of patients with recurrent sinusitis. J Allergy Clin Immunol 1990, 86:10–18. DOI: 10.1016/S0091-6749(05)80117-4